The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 16, 2021
Filed:
Dec. 18, 2019
Applicant:
Pathak Holdings Llc, Phoenix, AZ (US);
Inventor:
Chandrashekhar P. Pathak, Phoenix, AZ (US);
Assignee:
PATHAK HOLDINGS LLC, Phoenix, AZ (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/155 (2006.01); A61K 9/00 (2006.01); A61K 31/496 (2006.01); A61K 31/7036 (2006.01); A61K 47/34 (2017.01); A61M 37/00 (2006.01); A61K 9/16 (2006.01); A61K 31/337 (2006.01); A61K 31/727 (2006.01); A61L 27/50 (2006.01); A61L 27/54 (2006.01); A61K 41/00 (2020.01); A61K 31/37 (2006.01); A61K 31/573 (2006.01); A61M 5/30 (2006.01);
U.S. Cl.
CPC ...
A61K 31/155 (2013.01); A61K 9/0021 (2013.01); A61K 9/0024 (2013.01); A61K 9/0048 (2013.01); A61K 9/1641 (2013.01); A61K 9/1647 (2013.01); A61K 9/1658 (2013.01); A61K 31/337 (2013.01); A61K 31/37 (2013.01); A61K 31/496 (2013.01); A61K 31/573 (2013.01); A61K 31/7036 (2013.01); A61K 31/727 (2013.01); A61K 41/0028 (2013.01); A61K 47/34 (2013.01); A61L 27/50 (2013.01); A61L 27/54 (2013.01); A61M 37/0015 (2013.01); A61L 2400/06 (2013.01); A61M 5/3015 (2013.01); A61M 37/0069 (2013.01); A61M 37/0076 (2013.01); A61M 2037/0023 (2013.01); A61M 2205/3606 (2013.01); A61M 2205/3653 (2013.01); C12Y 304/21068 (2013.01); C12Y 304/24069 (2013.01);
Abstract
A method of forming an implant in a tissue can include: providing an injectable liquid composition comprising one or more precursors of a crosslinkable composition; injecting the injectable composition into the tissue at the rate of about 10-12000 injections per minute and/or at an amount of 1.0E-02 ml to 1.0E-16 ml per injection; and crosslinking the one or more precursors of the crosslinkable composition so as to form a crosslinked composition.